February 26, 2009

Notice concerning the decision of matters relating to acquisition of
company’s own shares.
(Acquisition of company’s own shares under the regulations of the
articles of association in accordance to paragraph 2, article 165 of the
corporation law)
The Hisamitsu Pharmaceutical Co., Ltd. (Head office: Tosu City, Saga Prefecture,
President: Hirotaka Nakatomi, hereinafter called “Hisamitsu Seiyaku”) hereby notices that
it resolved matters relating to acquisition of company’s own shares as follows under the
regulations of Article 156 of the Corporations Laws as being changed to read and applied
upon the regulations of Paragraph 3, Article 165 of the Corporation Law at the Meeting of
the Board of Directors held today.

1. Reason to acquire company’s own shares.
To improve capital efficiency and to attempt more distribution of profit to shareholders,
and to perform mobile capital policy corresponding to the change of managerial
environment.
2. Content of matters concerning acquisition.
(1)

Class of targeted shares to acquire:

Common shares of this company.
(2)

Total number of shares acquirable:

One (1) million shares (ceiling).
(Ratio to total number of issued shares [excluding company’s own shares] 1.13%)
(3)

Total amount of acquired value of share:
Three billion five hundred million
(3,500 Million) Yen (ceiling).
(4)

Period for acquisition:
From March 4, 2009 to March 31,
2009.
Reference: Condition of company’s own shares held as of January 31, 2009.
・
Total number of issued shares (excluding company’s own shares)
88,698,230 shares.
・
Number of company’s own shares 6,466,665 shares.